Stem Cell Therapies Still Facing Commercial Challenges – Pharmaceutical Executive (press release) (registration) (blog)
|
Stem Cell Therapies Still Facing Commercial Challenges
Pharmaceutical Executive (press release) (registration) (blog) A report from GBI Research states while the stem cell therapy pipeline is relatively large, with 330 products in active development across all stages, a number of obstacles remain before they become widely commercially viable. The company's survey of … Despite 330 products in pipeline, stem cell therapies still face commercial challenges |
